The ideal sequence: treating patients with CLL
Benefits of deacetylase inhibitors for leukemia therapy
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma
A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian
The challenges facing elderly AML treatment